The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis

BACKGROUND: In chronic diseases such as multiple sclerosis requiring lifelong treatment, studies on long-term outcomes are important. OBJECTIVE: To assess disability and magnetic resonance imaging-related outcomes in relapsing multiple sclerosis patients from a Phase 2 study of fingolimod 10 or more...

Descripción completa

Detalles Bibliográficos
Autores principales: Derfuss, T, Sastre-Garriga, J, Montalban, X, Rodegher, M, Wuerfel, J, Gaetano, L, Tomic, D, Azmon, A, Wolf, C, Kappos, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132565/
https://www.ncbi.nlm.nih.gov/pubmed/32284874
http://dx.doi.org/10.1177/2055217320907951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132565/
https://www.ncbi.nlm.nih.gov/pubmed/32284874
http://dx.doi.org/10.1177/2055217320907951

Ejemplares similares